These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32183176)

  • 21. Innate immunity and HCV.
    Heim MH
    J Hepatol; 2013 Mar; 58(3):564-74. PubMed ID: 23063572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune modulation by the hepatitis C virus core protein.
    Fernández-Ponce C; Dominguez-Villar M; Muñoz-Miranda JP; Arbulo-Echevarria MM; Litrán R; Aguado E; García-Cozar F
    J Viral Hepat; 2017 May; 24(5):350-356. PubMed ID: 28092420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of MicroRNA in Hepatitis C Virus Replication.
    Duan XQ; Li SL; Li YJ; Liu B; Zeng PB; Yang CH; Chen LM
    J Clin Transl Hepatol; 2013 Dec; 1(2):125-30. PubMed ID: 26355873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.
    Chigbu DI; Loonawat R; Sehgal M; Patel D; Jain P
    Cells; 2019 Apr; 8(4):. PubMed ID: 31027278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cells in hepatitis C: Current progress.
    Yoon JC; Yang CM; Song Y; Lee JM
    World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection.
    Xiang Y; Tang JJ; Tao W; Cao X; Song BL; Zhong J
    J Virol; 2015 Jul; 89(13):6805-16. PubMed ID: 25903345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging therapeutic strategies for hepatitis C virus infection.
    Sato K; Takagi H; Ichikawa T; Kakizaki S; Mori M
    Curr Mol Pharmacol; 2008 Jun; 1(2):130-50. PubMed ID: 20021428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organ system view of the hepatic innate immunity in HCV infection.
    Bang BR; Elmasry S; Saito T
    J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
    Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
    J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of hepatitis C virus vaccination: Recent update.
    Abdelwahab KS; Ahmed Said ZN
    World J Gastroenterol; 2016 Jan; 22(2):862-73. PubMed ID: 26811632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug abuse, innate immunity and hepatitis C virus.
    Zhang T; Li Y; Ho WZ
    Rev Med Virol; 2006; 16(5):311-27. PubMed ID: 16933366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
    Baumert TF; Fauvelle C; Chen DY; Lauer GM
    J Hepatol; 2014 Nov; 61(1 Suppl):S34-44. PubMed ID: 25443345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-virus interactions in hepatitis B and hepatitis C infection.
    Yoshio S; Kanto T
    J Gastroenterol; 2016 May; 51(5):409-20. PubMed ID: 26894594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
    Manickam C; Rajakumar P; Wachtman L; Kramer JA; Martinot AJ; Varner V; Giavedoni LD; Reeves RK
    J Virol; 2016 Oct; 90(20):9153-62. PubMed ID: 27489267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate and Adaptive Immune Responses in Chronic HCV Infection.
    Dustin LB
    Curr Drug Targets; 2017; 18(7):826-843. PubMed ID: 26302811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate Immune Evasion Mediated by Flaviviridae Non-Structural Proteins.
    Chen S; Wu Z; Wang M; Cheng A
    Viruses; 2017 Oct; 9(10):. PubMed ID: 28991176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Qi H; Chu V; Wu NC; Chen Z; Truong S; Brar G; Su SY; Du Y; Arumugaswami V; Olson CA; Chen SH; Lin CY; Wu TT; Sun R
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2018-2023. PubMed ID: 28159892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathogenesis of hepatitis C virus infection.
    Chang KM
    Clin Liver Dis; 2003 Feb; 7(1):89-105. PubMed ID: 12691460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.
    Thimme R; Binder M; Bartenschlager R
    FEMS Microbiol Rev; 2012 May; 36(3):663-83. PubMed ID: 22142141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
    Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.